Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection
Martina Biggioggero,1 Chiara Crotti,2 Andrea Becciolini,1 Ennio Giulio Favalli1 1Department of Rheumatology, Gaetano Pini Institute, Milan, Italy; 2Department of Clinical Sciences and Health Community, University of Milan, Division of Rheumatology, Gaetano Pini Institute, Milan, Italy Abstract: Rh...
Main Authors: | Biggioggero M, Crotti C, Becciolini A, Favalli EG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/tocilizumab-in-the-treatment-of-rheumatoid-arthritis-an-evidence-based-peer-reviewed-article-DDDT |
Similar Items
-
Sarilumab: patient-reported outcomes in rheumatoid arthritis
by: Crotti C, et al.
Published: (2018-08-01) -
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
by: Raimondo MG, et al.
Published: (2017-05-01) -
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
by: Crotti C, et al.
Published: (2017-01-01) -
Clinical efficacy of tocilizumab combined with leflunomide in the treatment of rheumatoid arthritis
by: Liang AO, et al.
Published: (2019-09-01) -
Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis
by: Martina Biggioggero, et al.
Published: (2019-10-01)